InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,106.28
(
1.15%
)
US TECH 100
17,286.79
(
1.82%
)
Dow Jones
38,274.42
(
0.50%
)
Brent Oil
88.15
(
0.00%
)
Bitcoin
63,813.78
(
-1.04%
)
Post# of 50894
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3156
Posts 961111
Boards Moderated 205
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 44697

Thursday, 05/23/2019 9:18:45 PM

Thursday, May 23, 2019 9:18:45 PM

Post# of 50894
Tenax Therapeutics (NASDAQ: TENX): Near-Term Phase 2 Results Expected to Drive Stock

Exclusive interview with Tenax Therapeutics (NASDAQ: TENX) CEO Anthony Ditonno.TENX is expected to report Phase 2 results for its pulmonary hypertension treatment by year end. Its innovative treatment is based on an established compound, approved in 60+ countries and cited in 1000+ publications, which provides a strong foundation that de-risks the development opportunity.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up